Tikva Allocell is a cell therapy company focused on a Second Generation Allogeneic EBV-Specific T cell (ALLO EBVST) platform to target difficult-to-treat cancers. At Tikva Allocell, our mission is to develop safe, effective, readily available and affordable “off-the-shelf” T cell therapies by lever...See more
Headquarter Singapore |
Countries of operation Singapore |
Year founded 2023 (1 year) |
Funding status Private |
Company type SME |
Founder, CEO
Office Manager
Senior associate research scientist
At a glanceThe company is owned by individual shareholder(s), it has no corporate shareholder.
Add filters
Job title | Name | Email | Country based in | Job Function | Seniority | |
|---|---|---|---|---|---|---|
Founder, CEO | hidden.item | hidden.item | hidden.item | |||
Office Manager | - | hidden.item | hidden.item | hidden.item | ||
Senior associate research scientist | - | hidden.item | hidden.item | hidden.item |
Share Capital - Ordinary shares: | hidden.item |
Sign up to view for free | |
Company | Incorporation date | Country of Registration | Share capital | Local SIC  |
|---|---|---|---|---|
| 13 Jul 2023 | Singapore | SGD 1 | 72106: RESEARCH AND EXPERIMENTAL DEVELOPMENT ON MEDICAL SCIENCE |
